Comparison of PET-based criteria of evaluation of response to immunotherapy in patients with advanced melanoma.

被引：0
|
作者：
Comito, Francesca [1 ]
Pagani, Rachele [1 ]
Aprile, Marta [1 ]
Dragonetti, Valentino [1 ]
Bonazzi, Norma [1 ]
Battisti, Giacomo [1 ]
Malizia, Claudio [1 ]
Nanni, Cristina [1 ]
机构：
[1] IRCCS Azienda Osped Univ Bologna, Bologna, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21536
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] PET-Based Prognostic Stratification In Patients With Advanced Melanoma Treated With Immunotherapy: A Criteria Comparison
    Bonazzi, N.
    Battisti, G.
    Dragonetti, V.
    Comito, F.
    Pagani, R.
    Aprile, M.
    Malizia, C.
    Melotti, B.
    Ardizzoni, A.
    Fanti, S.
    Nanni, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S232 - S232
  • [2] Predictive value and accuracy of PET modified response criteria for immunotherapy in patients with advanced melanoma
    Jamshidi, Zahr
    Hoellwerth, Magdalena
    Hitzl, Wolfgang
    Koelblinger, Peter
    Pirich, Christian
    Beheshti, Mohsen
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [3] A novel immunotherapy for advanced melanoma.
    Wang, X
    Chen, HY
    Lin, JR
    Xie, B
    Wu, L
    Yang, DM
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S72 - S73
  • [4] Factors predicting the use of immunotherapy for patients with advanced melanoma.
    Joseph, Richard Wayne
    Shillington, Alicia
    Macahilig, Cynthia
    Diede, Scott J.
    Dave, Vaidehi
    Harshaw, Qing
    Liu, Frank Xiaoqing
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Using machine learning to predict immunotherapy response in advanced melanoma.
    Johannet, Paul
    Coudray, Nicolas
    Donnelly, Douglas M.
    Jour, George
    Illa-Bochaca, Irineu
    Xia, Yuhe
    Johnson, Douglas Buckner
    Wheless, Lee E.
    Patrinely, James Randall
    Pavlick, Anna C.
    Weber, Jeffrey S.
    Zhong, Hua
    Tsirigos, Aristotelis
    Osmannyu, Iman
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Pathway-flux based biomarker for immunotherapy response in melanoma.
    Li, Jian
    Mei, Qi
    Cheng, Weiting
    Hu, Guangyuan
    Yuan, Xianglin
    Mansmann, Ulrich Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] PET-BASED RESPONSE CRITERIA IN LYMPHOMA: CURRENT STATUS AND FUTURE DIRECTIONS
    Meignan, M.
    ANNALS OF ONCOLOGY, 2014, 25
  • [8] Comparison of baseline patient characteristics in immunotherapy versus targeted therapy trials for advanced melanoma.
    Handa, Shivani
    Petrone, Giulia
    Rutledge, John R.
    Friedlander, Philip Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Response criteria for malignant melanoma. RECIST and irRC
    Spiro, J.
    Maintz, D.
    Persigehl, T.
    RADIOLOGE, 2015, 55 (02): : 127 - 135
  • [10] Predictive value and accuracy of [18F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma
    Ayati, Narjess
    Jamshidi-Araghi, Zahra
    Hoellwerth, Magdalena
    Schweighofer-Zwink, Gregor
    Hitzl, Wolfgang
    Koelblinger, Peter
    Pirich, Christian
    Beheshti, Mohsen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (09) : 2715 - 2726
12345